1. Home
  2. APM vs IDAI Comparison

APM vs IDAI Comparison

Compare APM & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APM
  • IDAI
  • Stock Information
  • Founded
  • APM 2010
  • IDAI 2016
  • Country
  • APM United Kingdom
  • IDAI United States
  • Employees
  • APM N/A
  • IDAI N/A
  • Industry
  • APM Biotechnology: Pharmaceutical Preparations
  • IDAI Computer Software: Prepackaged Software
  • Sector
  • APM Health Care
  • IDAI Technology
  • Exchange
  • APM Nasdaq
  • IDAI Nasdaq
  • Market Cap
  • APM 6.1M
  • IDAI 5.5M
  • IPO Year
  • APM 2018
  • IDAI N/A
  • Fundamental
  • Price
  • APM $0.93
  • IDAI $2.45
  • Analyst Decision
  • APM
  • IDAI
  • Analyst Count
  • APM 0
  • IDAI 0
  • Target Price
  • APM N/A
  • IDAI N/A
  • AVG Volume (30 Days)
  • APM 137.3K
  • IDAI 48.2K
  • Earning Date
  • APM 05-20-2025
  • IDAI 05-20-2025
  • Dividend Yield
  • APM N/A
  • IDAI N/A
  • EPS Growth
  • APM N/A
  • IDAI N/A
  • EPS
  • APM N/A
  • IDAI N/A
  • Revenue
  • APM N/A
  • IDAI $3,082,348.00
  • Revenue This Year
  • APM N/A
  • IDAI $65.46
  • Revenue Next Year
  • APM N/A
  • IDAI $12.00
  • P/E Ratio
  • APM N/A
  • IDAI N/A
  • Revenue Growth
  • APM N/A
  • IDAI N/A
  • 52 Week Low
  • APM $0.46
  • IDAI $0.15
  • 52 Week High
  • APM $7.49
  • IDAI $8.96
  • Technical
  • Relative Strength Index (RSI)
  • APM 52.79
  • IDAI 69.87
  • Support Level
  • APM $0.80
  • IDAI $1.94
  • Resistance Level
  • APM $0.96
  • IDAI $2.13
  • Average True Range (ATR)
  • APM 0.07
  • IDAI 0.16
  • MACD
  • APM -0.00
  • IDAI 0.07
  • Stochastic Oscillator
  • APM 68.36
  • IDAI 96.25

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility.

Share on Social Networks: